900 filings
Page 2 of 45
8-K
45t3nyiq1 agyj
28 Apr 23
Entry into a Material Definitive Agreement
6:09am
DEFA14A
xx4di
26 Apr 23
Additional proxy soliciting materials
3:37pm
8-K
6syzqo82kukb
26 Apr 23
CME Group Inc. Reports First-Quarter 2023 Financial Results
7:06am
8-K
g0q1njw77er4y
30 Mar 23
CME Group Appoints Tim McCourt as Global Head of Financial & OTC Products
4:08pm
DEFA14A
z69 nugps
22 Mar 23
Additional proxy soliciting materials
3:03pm
ARS
kvqj1o6yscmid 5f95wm
20 Mar 23
Annual report to shareholders
2:41pm
DEFA14A
19rcm3l
16 Mar 23
Additional proxy soliciting materials
5:29pm
8-K
uq32fd1ux 5kplqo
10 Mar 23
Departure of Directors or Certain Officers
4:38pm
8-K
gdsm 1f9r
28 Feb 23
Departure of Directors or Certain Officers
5:06pm
8-K
dmfc 9ucovcarylzt5xl
8 Feb 23
CME Group Inc. Reports Fourth-Quarter and Full-Year 2022 Financial Results
7:15am
8-K
17q0t
9 Dec 22
Amendments to Articles of Incorporation or Bylaws
9:52am
8-K
43vw5p 4hqspk22z
29 Nov 22
Regulation FD Disclosure
9:30am
8-K
ufraof a25p1rnn7x30
26 Oct 22
CME Group Inc. Reports Third-Quarter 2022 Financial Results
7:06am
UPLOAD
ssx7db x3z
25 Oct 22
Letter from SEC
12:00am
CORRESP
mf77wjcparzvpryv rq
30 Sep 22
Correspondence with SEC
12:00am
UPLOAD
rj7bv8 ko
21 Sep 22
Letter from SEC
12:00am